tiprankstipranks
Trending News
More News >
Innoviva Inc (INVA)
NASDAQ:INVA

Innoviva (INVA) Similar Stocks

Compare
332 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Innoviva
$19.51
$1.49B
14.00
9.73%
3 Buy
0 Hold
1 Sell
Moderate Buy
Xeris Pharmaceuticals
$9.08
$1.20B
-70.41
109.80%
4 Buy
0 Hold
0 Sell
Strong Buy
CureVac
$5.48
$927.75M
5.86
40.80%
Tourmaline Bio
$47.98
124.21%
LENZ Therapeutics
$16.89
$551.33M
-8.01
-46.38%
6 Buy
0 Hold
0 Sell
Strong Buy
Rapport Therapeutics, Inc.
$30.62
$1.52B
-11.37
65.87%
6 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
INVA
Innoviva
19.51
1.86
10.54%
XERS
Xeris Pharmaceuticals
7.28
3.78
108.00%
CVAC
CureVac
4.21
1.16
38.03%
TRML
Tourmaline Bio
47.98
26.14
119.69%
LENZ
LENZ Therapeutics
16.89
-15.12
-47.24%
RAPP
Rapport Therapeutics, Inc.
30.62
11.34
58.82%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts